Valuation: DaShenLin Pharmaceutical Group Co., Ltd.

Market Cap 20.4B 3.02B 2.61B 2.45B 2.23B 4.2B 289B 4.27B 28.76B 11.24B 145B 11.35B 11.11B 481B P/E 2026 *
13.7x
P/E 2027 * 11.9x
Enterprise Value 16.88B 2.5B 2.16B 2.03B 1.85B 3.47B 239B 3.53B 23.8B 9.3B 120B 9.4B 9.19B 398B EV / Sales 2026 *
0.56x
EV / Sales 2027 * 0.5x
Free-Float
34.77%
Yield 2026 *
5.03%
Yield 2027 * 5.54%
1 day-0.17%
1 week+2.28%
Current month-4.99%
1 month-6.96%
3 months-4.78%
6 months-6.82%
Current year+1.65%
1 week 17.86
Extreme 17.86
19.99
1 month 17.41
Extreme 17.41
19.99
Current year 14.39
Extreme 14.39
21.78
1 year 14.39
Extreme 14.39
21.78
3 years 11.92
Extreme 11.92
28.81
5 years 11.92
Extreme 11.92
39.47
10 years 11
Extreme 11.002785
61.63
Manager TitleAgeSince
Chief Executive Officer 44 27/02/2019
Director of Finance/CFO 44 09/05/2018
Human Resources Officer 48 -
Director TitleAgeSince
Director/Board Member 63 07/08/2016
Chairman 59 15/07/2013
Chairman 48 27/05/2015
Change 5-day change 1-year change 3-year change Capi.($)
-0.17%+2.28%+5.11%-38.24% 3.02B
-0.51%-1.90%-40.78%-16.87% 16.05B
+0.31%-11.07%-41.03%-32.89% 6.68B
-1.63%-3.19%-20.42%-16.70% 6.22B
0.00%+8.49%+2.82%-26.27% 4.32B
-2.57%-2.51%-19.09%-39.66% 3.31B
-1.77%-2.51%-43.84%-23.17% 3.04B
+0.22%-0.20%-13.06%-1.04% 2.64B
-0.08%-12.32%+62.70% - 2.43B
-0.33%+0.03%-7.98%+24.48% 1.59B
Average -0.65%-1.66%-11.56%-18.93% 4.93B
Weighted average by Cap. -0.61%-0.87%-22.70%-21.10%

Financials

2026 *2027 *
Net sales 29.91B 4.43B 3.83B 3.6B 3.27B 6.15B 424B 6.25B 42.17B 16.49B 212B 16.65B 16.29B 706B 33.03B 4.9B 4.23B 3.97B 3.62B 6.8B 468B 6.91B 46.57B 18.21B 235B 18.39B 17.99B 779B
Net income 1.48B 220M 190M 179M 162M 305M 21.05B 310M 2.09B 818M 10.54B 826M 808M 35.03B 1.71B 254M 220M 206M 188M 353M 24.31B 359M 2.42B 945M 12.17B 954M 934M 40.45B
Net Debt -3.52B -522M -451M -423M -385M -724M -49.89B -736M -4.96B -1.94B -24.99B -1.96B -1.92B -83.03B -4.01B -595M -513M -483M -439M -825M -56.85B -839M -5.65B -2.21B -28.47B -2.23B -2.18B -94.6B
Logo DaShenLin Pharmaceutical Group Co., Ltd.
DaShenLin Pharmaceutical Group Co Ltd is a China-based company principally engaged in the pharmaceutical retailing business. The Company is mainly engaged in the chain retail business of Chinese and Western patent medicines, ginseng and antler tonic medicinal materials and Chinese herbal medicine slices, health products, medical devices and other commodities. The Company is also involved in the production of Chinese herbal medicine slices, ginseng and antler tonic, health products, Chinese and Western patent medicines. The Company's brands include Dong Zi Yun Xuan, Cocoking, Nobe Huale, Dongteng Ejiao, and Fuer. The Company mainly conducts business within domestic market.
Employees
41,141
Date Price Change Volume
14/08/26 CN¥17.91 -0.17% 8,012,677
13/08/26 CN¥17.94 -1.10% 7,717,365
12/08/26 CN¥18.14 -3.82% 12,579,939
11/08/26 CN¥18.86 +3.46% 19,793,347
10/08/26 CN¥18.23 +4.11% 11,895,319
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
17.91CNY
Average target price
24.70CNY
Spread / Average Target
+37.91%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 603233 Stock